WuXi Biologics (Cayman) Inc.
2269
Rank in Stocks
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Share Price
$5.70
Market Cap
$23.45B
Change (1 day)
-9.51%
Change (1 year)
23.58%
Country
CN
Trade WuXi Biologics (Cayman) Inc. (2269)
Category
Healthcare
Number of shares outstanding for WuXi Biologics (Cayman) Inc. (2269)
Number of shares outstanding as of October 2026: 0
According to WuXi Biologics (Cayman) Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for WuXi Biologics (Cayman) Inc. (2269) from 2014 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2019 | 4.00B | 1.42% |
| 2018 | 3.94B | 22.31% |
| 2017 | 3.22B | -5.29% |
| 2016 | 3.40B | 0.00% |
| 2015 | 3.40B | 0.00% |
| 2014 | 3.40B | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
